Diagnostic and intervention value of implantable cardiac monitor in patients over 60 years of age with unexplained syncope
10.3760/cma.j.cn112148-20230906-00132
- VernacularTitle:植入型心电监测仪对60岁以上不明原因晕厥患者的诊断和干预价值研究
- Author:
Rui WANG
1
;
Yanfei ZHANG
;
Hongchao ZHANG
;
Jia WANG
;
Shuhui SHEN
;
Jiabin TONG
;
Junpeng LIU
;
You LYU
;
Jia CHONG
;
Zhilei WANG
;
Xin JIN
;
Lin SUN
;
Xu GAO
;
Yan DAI
;
Jing LIANG
;
Haitao LI
;
Tong ZOU
;
Jiefu YANG
Author Information
1. 北京医院心血管内科 国家老年医学中心，北京 100730
- Keywords:
Syncope;
Cardiac Syncope;
Implantable cardiac monitor;
Electrocardiography;
Arrhythmia;
Sick sinus syndrome;
Atrioventricular block;
Atrial fibrillation
- From:
Chinese Journal of Cardiology
2024;52(7):784-790
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the value of implantable cardiac monitor (ICM) in the diagnosis and treatment of patients over 60 years old with unexplained syncope.Methods:This was a multi-center, prospective cohort study. Between June 2018 and April 2021, patients over the age of 60 with unexplained syncope at Beijing Hospital, Fuwai Hospital, Beijing Anzhen Hospital and Puren Hospital were enrolled. Patients were divided into 2 groups based on their decision to receive ICM implantation (implantation group and conventional follow-up group). The endpoint was the recurrence of syncope and cardiogenic syncope as determined by positive cardiac arrhythmia events recorded at the ICM or diagnosed during routine follow-up. Kaplan‐Meier survival analysis was used to compare the differences of cumulative diagnostic rate between the 2 groups. A multivariate Cox regression analysis was performed to determine independent predictors of diagnosis of cardiogenic syncope in patients with unexplained syncope.Results:A total of 198 patients with unexplained syncope, aged (72.9±8.25) years, were followed for 558.0 (296.0,877.0) d, including 98 males (49.5%). There were 100 (50.5%) patients in the implantation group and 98 (49.5%) in the conventional follow-up group. Compared with conventional follow-up group, patients in the implantation group were older, more likely to have comorbidities, had a higher proportion of first degree atrioventricular block indicated by baseline electrocardiogram, and had a lower body mass index (all P<0.05). During the follow-up period, positive cardiac arrhythmia events were recorded in 58 (58.0%) patients in the ICM group. The diagnosis rate (42.0% (42/100) vs. 4.1% (4/98), P<0.001) and the intervention rate (37.0% (37/100) vs. 2.0% (2/98), P<0.001) of cardiogenic syncope in the implantation group were higher than those in the conventional follow-up group (all P<0.001). Kaplan-Meier survival analysis showed that the cumulative diagnostic rate of cardiogenic syncope was significantly higher in the implantation group than in the traditional follow-up group ( HR=11.66, 95% CI 6.49-20.98, log-rank P<0.001). Multivariate analysis indicated that ICM implantation, previous atrial fibrillation, diabetes mellitus or first degree atrioventricular block in baseline electrocardiogram were independent predictors for cardiogenic syncope (all P<0.05). Conclusions:ICM implantation improves the diagnosis and intervention rates in patients with unexplained syncope, and increases diagnostic efficiency in patients with unexplained syncope.
